Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment
NCT ID: NCT05901766
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
600 participants
INTERVENTIONAL
2026-01-01
2027-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
1. What are the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers on infant development, as measured by electroencephalography/visual evoked potentials?
2. What are the effects of iodine-containing multiple micronutrient supplements on breast milk concentrations of iodine, and infant iodine and thyroid status?
3. How do iodine and iron interact with each other to affect thyroid function in the mother during lactation?
Participants will be randomized to receive a daily multiple micronutrient tablet containing iodine (UNIMAPP) for 6 months postpartum, or routine postnatal care per Ethiopia Ministry of Health. Mothers will provide a breast milk sample and blood at 3 and 6 months postpartum. Infants will provide a urine sample and drop of blood, and have a neurodevelopmental assessment at 3 and 6 months.
Researchers will compare the groups that received the iodine-containing micronutrient supplement with the group that received routine care and see if there were any benefits on infant development and iodine and thyroid status in the mother and baby.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RCT of Iodine-containing MNPs vs Oral Iodized Oil to Prevent Iodine Deficiency in Weaning Infants
NCT02421653
Study of the Effect of Iodized Oil Supplementation During Infancy
NCT01126125
Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women
NCT02464111
Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months
NCT02280330
Maternal Iodine Supplementation and Effects on Thyroid Function and Child Development
NCT00791466
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iodine Containing Multiple Micronutrient (UNIMAP)
UNIMAP 1 tablet po once daily from birth to 6 months postpartum
UNIMAP Multiple Micronutrient Supplement
Iodine Containing Multiple Micronutrient Supplement once daily
Routine postnatal care
Routine postnatal care per Ethiopian Ministry of Health guidelines
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UNIMAP Multiple Micronutrient Supplement
Iodine Containing Multiple Micronutrient Supplement once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Birth weight \>2000g
Exclusion Criteria
* Multiple pregnancy
* Infant with major congenital anomalies
* Infants with severe morbidity or developmental disorder
* Mother with HIV or chronic renal disease
* Plan to move out of study catchment area
* Does not agree to follow up or EEG/VEP
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Addis Continental Institute of Public Health
OTHER
Brigham and Women's Hospital
OTHER
Johns Hopkins Bloomberg School of Public Health
OTHER
University of South Carolina
OTHER
Brown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Shee CC Lee
Levinger Family Professor of Pediatrics
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021P002634
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.